A Review on Picrosides Targeting NFκB and its Proteins for Treatment of Breast Cancer

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• Breast cancer is a leading cause of death in women globally, with drug resistance limiting current treatments like chemotherapy.
• Natural phytochemicals are being investigated as potentially less toxic alternatives for cancer therapy.
• Nuclear factor kappa B (NF-κB) signaling pathways are implicated in various cancers, presenting a potential therapeutic target.

Purpose of the Study:

• To review the potential anticancer activity of picrosides by examining their interaction with NF-κB and associated proteins.
• To elucidate the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties of picrosides for breast cancer treatment potential.
• To perform in silico analysis to understand the binding interactions between picrosides and NF-κB.

Main Methods:

• Literature review on NF-κB signaling in cancer.
• Analysis of existing data on picrosides and their known biological activities.
• In silico molecular docking studies to predict binding modes of Picroside II with NF-κB.
• Review of ADMET properties of picrosides.

Main Results:

• NF-κB is a critical regulator in normal and cancerous cells, making it a viable drug target.
• No prior reports exist on picrosides targeting NF-κB for anticancer effects.
• In silico analysis suggests potential binding interactions between Picroside II and NF-κB.
• Preliminary ADMET analysis indicates favorable properties for picrosides as potential drug candidates.

Conclusions:

• Picrosides show promise as a novel therapeutic strategy for breast cancer by potentially modulating NF-κB signaling.
• Further research, including experimental validation, is warranted to confirm the anticancer efficacy and safety of picrosides.
• Picrosides represent a potential lead compound for developing new breast cancer drugs with improved safety profiles.